GO:0140035 ubiquitin-like protein reader activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140035 (ubiquitin-like protein reader activity) is a molecular function in which a reader protein binds a target carrying a ubiquitin-like modification and brings it into contact with another protein to coordinate their functions.
• Reader activity is essential for interpreting ubiquitin-like signals such as SUMO, NEDD8, ISG15, and MARUbylation, converting modification marks into downstream biological outcomes.
• Reader domains include ubiquitin-interacting motifs (UIMs), ubiquitin-associated (UBA) domains, and other ubiquitin-like binding modules that selectively recognize distinct chain types.
• Dysregulated reader activity contributes to cancer, immune disorders, and proteostasis-related diseases, making these proteins attractive therapeutic targets.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of reader function in disease-relevant pathways.
• Advanced proteomic and structural methods, including thioether-mediated ubiquitinated protein probes, allow direct interrogation of reader-substrate interactions.
Description
Ubiquitin-like protein reader activity (GO:0140035) defines a molecular adaptor function in which a protein recognizes and binds a target protein bearing a ubiquitin-like modification and then brings that target into contact with another protein so the two can function in a coordinated manner. This activity is central to signal transduction because ubiquitin and ubiquitin-like modifiers (SUMO, NEDD8, ISG15, and others) are attached to substrates by writer enzymes and removed by erasers, while readers interpret the modification to drive specific outcomes. Without readers, ubiquitin-like modifications would remain largely silent marks. The term is therefore critical for understanding how cells convert post-translational modifications into decisions about protein stability, localization, and complex assembly. Mechanistically, reader activity depends on modular domains that selectively engage ubiquitin-like moieties. For example, the ubiquitin-interacting motif-like domain of Met4 selectively binds K48 polyubiquitin chains, illustrating how readers discriminate between chain topologies. Reader-writer E3 ligases such as RNF114 and RNF166 extend K11 polyubiquitin onto sites of MARUbylation, showing that reader and writer functions can be physically coupled. Such coupling ensures that modification and interpretation are spatially and temporally coordinated. For researchers, GO:0140035 provides a framework to study how ubiquitin-like signals are decoded in cancer, immunity, and proteostasis. The activity is experimentally tractable through CRISPR-based models, affinity probes, and proteomic workflows. Understanding reader specificity and regulation is essential for targeting these pathways therapeutically.
ubiquitin-like protein reader activity At A Glance
| GO ID | GO:0140035 |
|---|---|
| GO term | ubiquitin-like protein reader activity |
| Ontology | molecular_function |
| Synonym | ubiquitination-like modification-dependent protein binding; ubiquitination-like protein reader activity |
| Major function | Binds a ubiquitin-like modified target and brings it into contact with another protein to coordinate their functions |
| Modifiers recognized | Ubiquitin and ubiquitin-like proteins such as SUMO, NEDD8, ISG15, and MARUbylation |
| Representative reader domains | UIM, UBA, and other ubiquitin-like binding modules |
| Coupled enzymatic activity | Reader-writer E3 ligases can extend polyubiquitin chains on modified substrates |
| Experimental probes | Thioether-mediated ubiquitinated protein probes for affinity and activity studies |
What Is GO:0140035?
In simple terms, ubiquitin-like protein reader activity is the ability of a protein to grab onto another protein that has a ubiquitin-like tag and then introduce it to a third protein so they can work together. The official definition describes a molecular adaptor that recognizes and binds a target protein containing a ubiquitin-like modification and that brings the target protein into contact with another protein to allow those proteins to function in a coordinated way. This function is distinct from writing (attaching) or erasing (removing) the modification; readers interpret the mark. Synonyms include ubiquitination-like modification-dependent protein binding and ubiquitination-like protein reader activity.
Why Is ubiquitin-like protein reader activity Important in Cell Biology?
Ubiquitin-like protein reader activity is important because it converts post-translational modifications into functional outcomes. Readers determine whether a ubiquitin-like mark leads to protein degradation, altered localization, complex assembly, or signaling activation. This makes GO:0140035 a central node in pathways controlling cell growth, immune responses, and proteostasis. Dysregulation of reader proteins is linked to cancer, where altered recognition of ubiquitinated substrates can drive survival signaling and drug resistance. In immunology, readers of ubiquitin-like modifications help control inflammatory and antiviral responses. Because readers are modular and druggable, they are attractive targets for therapeutic intervention.
• Readers decode ubiquitin-like signals, converting them into coordinated protein-protein interactions.
• They are essential for selective autophagy and protein quality control.
• Reader-writer E3 ligases couple substrate modification to downstream signaling.
• Dysregulated reader activity contributes to cancer progression and therapy resistance.
• Readers participate in immune signaling and host defense.
• Chain-type specificity (e.g., K48 vs. K11) determines biological outcome.
• Reader domains are structurally tractable and can be targeted by small molecules.
• CRISPR models enable causal testing of reader function in disease.
• Proteomic probes allow direct detection of reader-substrate complexes.
• Understanding reader biology informs drug discovery for undruggable pathways.
Molecular Mechanism of ubiquitin-like protein reader activity
Recognition of ubiquitin-like modifications
In simple terms: The reader first finds and binds the ubiquitin-like tag on a target protein.
Reader proteins contain domains such as UIM or UBA that selectively engage ubiquitin or ubiquitin-like moieties. The ubiquitin-interacting motif-like domain of Met4, for example, selectively binds K48 polyubiquitin chains, demonstrating chain-type discrimination. This recognition step is modification-dependent and often requires a specific linkage or conformational state.
Target engagement and adaptor function
In simple terms: Once bound, the reader acts as a bridge to bring the modified protein together with another protein.
The defining feature of GO:0140035 is that the reader brings the modified target into contact with another protein to allow coordinated function. This adaptor role is distinct from simple binding; it creates a functional complex. For instance, TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signaling, illustrating how reader-like recognition controls pathway output.
Coupling to writer and eraser enzymes
In simple terms: Some readers also carry enzymatic activity that adds more ubiquitin-like tags, linking reading to writing.
RNF114 and RNF166 exemplify reader-writer E3 ligases that extend K11 polyubiquitin onto sites of MARUbylation. This coupling ensures that recognition of a modification is immediately followed by further modification, amplifying or altering the signal. Such bifunctional proteins blur the line between reader and writer but remain dependent on initial recognition.
Regulation by modification state and cellular context
In simple terms: The reader's activity depends on which tags are present and what else is happening in the cell.
Reader activity is regulated by the availability of modified substrates, the type of ubiquitin-like modification, and competing erasers. For example, N6-methyladenosine-modified USP13 regulates stabilization of autophagy-related protein 5, linking RNA modification to ubiquitin-dependent proteostasis. SUMO pathway components also modulate reader accessibility and substrate selection.
Experimental interrogation with probes and traps
In simple terms: Scientists use chemical tools to catch readers in the act.
Thioether-mediated protein ubiquitination enables construction of affinity- and activity-based ubiquitinated protein probes that can capture reader proteins. Strategies to trap enzyme-substrate complexes mimicking Michaelis intermediates during E3-mediated ubiquitin-like protein ligation further allow structural and mechanistic analysis. These tools are essential for defining reader specificity and kinetics.
Key Genes Involved in GO:0140035 ubiquitin-like protein reader activity
The following genes and proteins represent major components and regulators of ubiquitin-like protein reader activity, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RNF114 | Reader-writer E3 ligase extending K11 polyubiquitin on MARUbylated substrates | Model for coupled reader-writer function in stress responses |
| RNF166 | Reader-writer E3 ligase with similar MARUbylation-linked activity | Comparative studies of reader specificity |
| TRAF2 | Ubiquitin-dependent signaling adaptor regulating mTORC2 | Cancer and metabolic signaling models |
| OTUD7B | Deubiquitinase governing a ubiquitin switch with TRAF2 | Study of eraser-reader interplay |
| USP13 | Deubiquitinase stabilized by m6A modification, regulates autophagy | Autophagy and drug resistance models |
| ATG5 | Autophagy-related protein stabilized via USP13 | Proteostasis and cancer therapy studies |
| Met4 | Contains UIM-like domain selectively binding K48 polyubiquitin | Chain-type specificity research |
| SUMO1 | Ubiquitin-like modifier recognized by SUMO readers | SUMO pathway studies |
| SUMO2/3 | Poly-SUMO chains that recruit reader proteins | Stress response and nuclear function |
| NEDD8 | Ubiquitin-like modifier with dedicated readers | Cullin-RING ligase regulation |
| ISG15 | Ubiquitin-like modifier in immune signaling | Antiviral and innate immunity models |
| UBB | Ubiquitin precursor providing ubiquitin moieties | Core ubiquitin biology |
| UBA1 | E1 activating enzyme for ubiquitin | Upstream pathway control |
| RNF4 | SUMO-targeted ubiquitin ligase with reader-like SUMO binding | SUMO-ubiquitin crosstalk |
| SQSTM1/p62 | Ubiquitin-binding autophagy receptor | Selective autophagy research |
| OPTN | Ubiquitin-binding adaptor in autophagy and NF-kB | Neurodegeneration and immunity |
How Is ubiquitin-like protein reader activity Regulated?
Ubiquitin-like protein reader activity is regulated at multiple levels. The abundance and modification state of substrates determine reader engagement, as seen with m6A-modified USP13 controlling ATG5 stabilization. Competing eraser enzymes such as OTUD7B can reverse ubiquitin signals and terminate reader-dependent complexes. Reader-writer E3 ligases like RNF114 and RNF166 couple recognition to further ubiquitination, creating feedback loops. Additionally, the SUMO pathway dynamically regulates reader accessibility through conjugation and deconjugation cycles. Cellular stress, immune signals, and metabolic cues can alter reader expression or localization, thereby tuning pathway output.
ubiquitin-like protein reader activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| USP13 | Gastrointestinal stromal tumor, imatinib resistance | Knockout and point-mutation cell lines |
| ATG5 | Autophagy dysregulation in cancer | Knock-in reporter for stabilization |
| TRAF2 | mTORC2-driven cancer and metabolic disease | Knockout and overexpression models |
| OTUD7B | Ubiquitin switch in cancer and immunity | Point-mutation of catalytic domain |
| SQSTM1/p62 | Neurodegeneration and selective autophagy | Knockout and tagged knock-in |
Cancer and therapy resistance
Dysregulated ubiquitin-like reader activity contributes to cancer by stabilizing pro-survival proteins and promoting drug resistance. In gastrointestinal stromal tumors, m6A-modified USP13 induces pro-survival autophagy and imatinib resistance by stabilizing ATG5, linking reader-dependent proteostasis to therapeutic failure. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signaling, a pathway frequently altered in cancer. Targeting reader-writer E3 ligases such as RNF114 and RNF166 may disrupt these adaptive responses.
Immune and inflammatory disorders
Ubiquitin-like modifications are critical in innate immunity. N6-methyladenosine modification controls circular RNA immunity, and readers of ubiquitin-like marks participate in antiviral signaling. ISG15, a ubiquitin-like modifier, is directly involved in host defense, and its readers help coordinate immune responses. Dysregulation can lead to autoinflammation or impaired pathogen clearance.
Neurodegeneration and proteostasis
Reader proteins that recognize ubiquitin chains are central to protein quality control. Autophagy receptors such as SQSTM1/p62 and OPTN bind ubiquitinated cargo and deliver it for degradation. When reader activity is impaired, toxic protein aggregates accumulate, contributing to neurodegenerative diseases. The SUMO pathway also modulates neuronal stress responses through reader-dependent interactions.
From ubiquitin-like protein reader activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of reader activity alter substrate stability? | CRISPR knockout of reader gene followed by proteomics |
| Does a specific reader domain mediate chain-type selectivity? | Point mutation in UIM/UBA domain |
| Can a disease-associated mutation alter reader function? | Knock-in of patient mutation |
| Where does the reader localize in cells? | Tagged knock-in with fluorescent protein |
| Does overexpression of reader drive pathway activation? | Doxycycline-inducible overexpression |
| Which genes cooperate with the reader? | CRISPR library screening and bioinformatics |
How to Study the ubiquitin-like protein reader activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Affinity proteomics | Reader-substrate interactions | Identifying novel readers |
| Thioether-mediated probes | Activity-based reader capture | Probe development |
| Michaelis intermediate trapping | Enzyme-substrate complexes | Structural studies |
| CRISPR knockout | Loss-of-function phenotype | Causal gene testing |
| Point mutation | Domain-specific function | Chain selectivity |
| Knock-in reporter | Localization and dynamics | Live-cell imaging |
| Overexpression | Gain-of-function effects | Pathway activation |
Proteomic identification of reader-substrate complexes
Affinity purification coupled to mass spectrometry can identify proteins that bind ubiquitin-like modified substrates. Thioether-mediated ubiquitinated protein probes enable capture of reader proteins with high specificity. These approaches define the reader interactome and reveal chain-type preferences.
Structural and biochemical characterization
Trapping enzyme-substrate complexes that mimic Michaelis intermediates during E3-mediated ubiquitin-like protein ligation allows structural analysis of reader engagement. Such methods reveal how reader domains discriminate among ubiquitin-like modifiers and chain topologies.
CRISPR-based functional genomics
Knockout, point-mutation, and knock-in models enable causal testing of reader genes. For example, disrupting RNF114 or RNF166 can reveal their roles in MARUbylation-dependent signaling. Combining CRISPR with proteomics or autophagy assays links genotype to pathway output.
Cell-based signaling and autophagy assays
Reporter assays for mTORC2, NF-kB, or autophagy flux measure the functional consequences of reader activity. These assays are often paired with knockout or overexpression to establish directionality.
How CRISPR Can Be Used to Study GO:0140035 ubiquitin-like protein reader activity
Knockout
CRISPR knockout of reader genes such as RNF114 or RNF166 eliminates protein function and reveals loss-of-function phenotypes in MARUbylation-dependent pathways. Knockout models are essential for determining whether a candidate reader is required for substrate stabilization or signaling.
Point Mutation
Point mutations in reader domains (e.g., UIM or UBA) can abolish binding to specific ubiquitin-like chains while preserving overall protein structure. These models dissect domain-specific contributions to reader activity and disease.
Knock-in
Knock-in of tagged or patient-derived mutations allows tracking of reader localization and function in physiologically relevant contexts. For example, tagging endogenous USP13 can reveal its stabilization by m6A modification.
Overexpression
Overexpression of reader proteins can drive pathway activation or dominant-negative effects, as seen with TRAF2 in mTORC2 signaling. Inducible systems provide temporal control for studying dynamic reader functions.
How EDITGENE Supports ubiquitin-like protein reader activity Research
Researchers studying ubiquitin-like protein reader activity-related genes often need to determine whether a candidate gene is causally involved in substrate recognition, complex assembly, or disease progression. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for ubiquitin-like protein reader activity research.
Frequently Asked Questions About ubiquitin-like protein reader activity
What is ubiquitin-like protein reader activity?
It is a molecular function (GO:0140035) where a protein binds a target carrying a ubiquitin-like modification and brings it into contact with another protein to coordinate their functions.
What genes are involved in ubiquitin-like protein reader activity?
Key genes include RNF114, RNF166, TRAF2, OTUD7B, USP13, and Met4, among others.
What is the GO ID for ubiquitin-like protein reader activity?
The GO ID is GO:0140035.
How does ubiquitin-like protein reader activity differ from ubiquitination?
Ubiquitination is the attachment of ubiquitin; reader activity is the recognition and interpretation of that modification to form functional complexes.
What diseases are linked to ubiquitin-like protein reader activity?
Cancers such as gastrointestinal stromal tumors, immune disorders, and neurodegenerative diseases involving proteostasis.
What domains mediate ubiquitin-like protein reader activity?
Common domains include UIM and UBA, which selectively bind ubiquitin or ubiquitin-like chains.
Can CRISPR be used to study ubiquitin-like protein reader activity?
Yes, knockout, point-mutation, knock-in, and overexpression models enable causal dissection of reader function.
What methods detect ubiquitin-like protein reader interactions?
Affinity proteomics, thioether-mediated probes, and Michaelis intermediate trapping are commonly used.
Is ubiquitin-like protein reader activity druggable?
Reader domains are structurally tractable and are being explored as therapeutic targets.
What is the role of reader-writer E3 ligases?
They couple recognition of ubiquitin-like modifications to further ubiquitination, amplifying signaling.
Conclusion
Ubiquitin-like protein reader activity (GO:0140035) is a fundamental molecular function that translates ubiquitin-like modifications into coordinated protein-protein interactions. Its dysregulation is implicated in cancer, immune disorders, and neurodegeneration, making it a high-priority research area. Advances in CRISPR modeling and chemical probes now allow precise interrogation of reader biology. Understanding these mechanisms will accelerate the development of targeted therapies.
References
- 1. Martín-Rufo R et al.. 2025. The SUMO Pathway.. Methods Mol Biol 2957:1-15 PMID: 40875111
- 2. Chen YG et al.. 2019. N6-Methyladenosine Modification Controls Circular RNA Immunity.. Mol Cell 76(1):96-109.e9 PMID: 31474572
- 3. Gao Z et al.. 2023. N(6)-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors.. Cell Death Differ 30(2):544-559 PMID: 36528756
- 4. Lacoursiere RE et al.. 2025. RNF114 and RNF166 exemplify reader-writer E3 ligases that extend K11 polyubiquitin onto sites of MARUbylation.. EMBO J 44(21):5993-6018 PMID: 41039157
- 5. Wang B et al.. 2017. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling.. Nature 545(7654):365-369 PMID: 28489822
- 6. Streich FC Jr et al.. 2018. Strategies to Trap Enzyme-Substrate Complexes that Mimic Michaelis Intermediates During E3-Mediated Ubiquitin-Like Protein Ligation.. Methods Mol Biol 1844:169-196 PMID: 30242710
- 7. Villamil M et al.. 2022. The Ubiquitin Interacting Motif-Like Domain of Met4 Selectively Binds K48 Polyubiquitin Chains.. Mol Cell Proteomics 21(1):100175 PMID: 34763062
- 8. Davidson GA et al.. 2025. Thioether-mediated protein ubiquitination in constructing affinity- and activity-based ubiquitinated protein probes.. Nat Protoc 20(11):3239-3269 PMID: 40281337
